Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 19, 17-18 (2020)
doi: https://doi.org/10.1038/d41573-019-00046-3
Acknowledgements
The authors thank A. Halczuk for help with some of the analyses.
Updates & Corrections
-
Update 29 April 2019: The article has been updated to include a reference to a previous study on fragmentation in the biopharmaceutical industry by Goldsmith and Varela (Drug Discov. Today 22, 433–439; 2017).
Supplementary Information
Competing Interests
All authors of this article are employees of McKinsey & Company, a management consultancy that works with the world's leading biopharmaceutical companies on innovation issues. The analysis in this study was funded by McKinsey's Pharmaceuticals and Medical Products practice and undertaken independently of any other organizations.